GLOBAL BIOENERGIES SA (ALGBE.PA) Fundamental Analysis & Valuation

EPA:ALGBE • FR0011052257

Current stock price

0.0185 EUR
0 (-7.5%)
Last:

This ALGBE.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. ALGBE.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALGBE has reported negative net income.
  • In the past year ALGBE has reported a negative cash flow from operations.
  • In the past 5 years ALGBE always reported negative net income.
  • ALGBE had a negative operating cash flow in each of the past 5 years.
ALGBE.PA Yearly Net Income VS EBIT VS OCF VS FCFALGBE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

  • ALGBE has a Return On Assets of -60.73%. This is amonst the worse of the industry: ALGBE underperforms 94.59% of its industry peers.
  • The Return On Equity of ALGBE (-346.31%) is worse than 93.24% of its industry peers.
Industry RankSector Rank
ROA -60.73%
ROE -346.31%
ROIC N/A
ROA(3y)-54.57%
ROA(5y)-48.79%
ROE(3y)-195.4%
ROE(5y)-183.82%
ROIC(3y)N/A
ROIC(5y)N/A
ALGBE.PA Yearly ROA, ROE, ROICALGBE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for ALGBE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALGBE.PA Yearly Profit, Operating, Gross MarginsALGBE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5K -10K -15K -20K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. ALGBE.PA Health Analysis

2.1 Basic Checks

  • ALGBE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ALGBE has about the same amout of shares outstanding than it did 1 year ago.
  • ALGBE has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, ALGBE has a worse debt to assets ratio.
ALGBE.PA Yearly Shares OutstandingALGBE.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ALGBE.PA Yearly Total Debt VS Total AssetsALGBE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • ALGBE has an Altman-Z score of -2.52. This is a bad value and indicates that ALGBE is not financially healthy and even has some risk of bankruptcy.
  • ALGBE has a worse Altman-Z score (-2.52) than 91.89% of its industry peers.
  • A Debt/Equity ratio of 2.78 is on the high side and indicates that ALGBE has dependencies on debt financing.
  • The Debt to Equity ratio of ALGBE (2.78) is worse than 93.24% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.78
Debt/FCF N/A
Altman-Z -2.52
ROIC/WACCN/A
WACC4.52%
ALGBE.PA Yearly LT Debt VS Equity VS FCFALGBE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M

2.3 Liquidity

  • ALGBE has a Current Ratio of 2.86. This indicates that ALGBE is financially healthy and has no problem in meeting its short term obligations.
  • ALGBE's Current ratio of 2.86 is amongst the best of the industry. ALGBE outperforms 82.43% of its industry peers.
  • A Quick Ratio of 2.73 indicates that ALGBE has no problem at all paying its short term obligations.
  • ALGBE's Quick ratio of 2.73 is amongst the best of the industry. ALGBE outperforms 93.24% of its industry peers.
Industry RankSector Rank
Current Ratio 2.86
Quick Ratio 2.73
ALGBE.PA Yearly Current Assets VS Current LiabilitesALGBE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. ALGBE.PA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 33.31% over the past year.
  • ALGBE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -88.90%.
  • Measured over the past years, ALGBE shows a very strong growth in Revenue. The Revenue has been growing by 25.15% on average per year.
EPS 1Y (TTM)33.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.52%
Revenue 1Y (TTM)-88.9%
Revenue growth 3Y52.9%
Revenue growth 5Y25.15%
Sales Q2Q%-85.13%

3.2 Future

  • ALGBE is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -5.13% yearly.
  • ALGBE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.48% yearly.
EPS Next Y22.81%
EPS Next 2Y-5.13%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.97%
Revenue Next 2Y0.48%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALGBE.PA Yearly Revenue VS EstimatesALGBE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2M 4M 6M
ALGBE.PA Yearly EPS VS EstimatesALGBE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -1 -2 -3

More info and screens

Find the best growth stocksShow best growing peers

0

4. ALGBE.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • ALGBE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALGBE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALGBE.PA Price Earnings VS Forward Price EarningsALGBE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALGBE.PA Per share dataALGBE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.1 -0.2 -0.3 -0.4

4.3 Compensation for Growth

  • A cheap valuation may be justified as ALGBE's earnings are expected to decrease with -5.13% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-5.13%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALGBE.PA Dividend Analysis

5.1 Amount

  • No dividends for ALGBE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

ALGBE.PA Fundamentals: All Metrics, Ratios and Statistics

GLOBAL BIOENERGIES SA

EPA:ALGBE (11/28/2025, 7:00:00 PM)

0.0185

0 (-7.5%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)10-01
Earnings (Next)02-02
Inst Owners1.07%
Inst Owner ChangeN/A
Ins Owners2.68%
Ins Owner ChangeN/A
Market Cap336.14K
Revenue(TTM)360.60K
Net Income(TTM)-5.86M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.93
P/FCF N/A
P/OCF N/A
P/B 0.2
P/tB 0.21
EV/EBITDA N/A
EPS(TTM)-0.32
EYN/A
EPS(NY)-0.23
Fwd EYN/A
FCF(TTM)-0.44
FCFYN/A
OCF(TTM)-0.41
OCFYN/A
SpS0.02
BVpS0.09
TBVpS0.09
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -60.73%
ROE -346.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-54.57%
ROA(5y)-48.79%
ROE(3y)-195.4%
ROE(5y)-183.82%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score0
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 2.78
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 18.66%
Cap/Sales 129.34%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.86
Quick Ratio 2.73
Altman-Z -2.52
F-Score0
WACC4.52%
ROIC/WACCN/A
Cap/Depr(3y)101.02%
Cap/Depr(5y)112%
Cap/Sales(3y)139.76%
Cap/Sales(5y)838.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.52%
EPS Next Y22.81%
EPS Next 2Y-5.13%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-88.9%
Revenue growth 3Y52.9%
Revenue growth 5Y25.15%
Sales Q2Q%-85.13%
Revenue Next Year0.97%
Revenue Next 2Y0.48%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y29.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year29.13%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y3.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4.94%
OCF growth 3YN/A
OCF growth 5YN/A

GLOBAL BIOENERGIES SA / ALGBE.PA Fundamental Analysis FAQ

What is the fundamental rating for ALGBE stock?

ChartMill assigns a fundamental rating of 2 / 10 to ALGBE.PA.


Can you provide the valuation status for GLOBAL BIOENERGIES SA?

ChartMill assigns a valuation rating of 0 / 10 to GLOBAL BIOENERGIES SA (ALGBE.PA). This can be considered as Overvalued.


Can you provide the profitability details for GLOBAL BIOENERGIES SA?

GLOBAL BIOENERGIES SA (ALGBE.PA) has a profitability rating of 0 / 10.